Cardiovalve Ltd.
Clinical trials sponsored by Cardiovalve Ltd., explained in plain language.
-
New Catheter-Based valve offers hope for High-Risk heart patients
Disease control OngoingThis study tests a new device that fixes a severe leaky heart valve (mitral regurgitation) without open-heart surgery. It is for 30 people who are too high-risk for traditional surgery. The device is threaded through a vein in the leg to the heart, and the study will check if it …
Phase: NA • Sponsor: Cardiovalve Ltd. • Aim: Disease control
Last updated May 17, 2026 11:38 UTC
-
New heart valve procedure aimed at High-Risk patients, but study never started
Disease control TerminatedThis study planned to test a new device called the Cardiovalve, which is placed through a leg vein to replace a leaky mitral heart valve without open-chest surgery. It was designed for people with severe mitral regurgitation who were too high-risk for traditional surgery. However…
Phase: NA • Sponsor: Cardiovalve Ltd. • Aim: Disease control
Last updated May 17, 2026 11:35 UTC
-
New heart valve without open surgery: hope for High-Risk patients
Disease control ENROLLING_BY_INVITATIONThis study tests a new replacement heart valve for people with severe mitral regurgitation (a leaky heart valve) who are too high-risk for open-heart surgery. The valve is delivered through a blood vessel in the leg, avoiding a large chest incision. The study will enroll 10 parti…
Phase: NA • Sponsor: Cardiovalve Ltd. • Aim: Disease control
Last updated May 07, 2026 18:38 UTC
-
Promising heart valve study pulled before it began
TerminatedThis study planned to test a new device called the Cardiovalve for people with severe tricuspid regurgitation (a leaky heart valve). The goal was to see if the device could safely replace the valve and reduce leakage. However, the study was withdrawn before any participants were …
Phase: NA • Sponsor: Cardiovalve Ltd.
Last updated May 15, 2026 11:55 UTC